|
Art. 93c Transitional provision to the Amendment of 11 March 2022 156
1 Substances and preparations may be supplied to third parties with the previous labelling until 31 December 2025. 2 If a manufacturer intends to conduct tests on vertebrates, it must by 31 October 2023 comply with the advance enquiry obligation in accordance with Article 31 paragraphs 1 and 2 for any substance that was placed on the market before this amendment comes into force and which is now subject to the notification obligation. If it complies with this obligation, it may continue to place the substance on the market without notification until 30 April 2027. The Notification Authority may extend the period by a maximum of two years. If two or more manufacturers intend to give notification of the same substance, the Notification Authority shall inform the manufacturers of this immediately on expiry of the deadline for the advance enquiry. Article 31 paragraph 4 applies by analogy. 3 New substances for which notification was not given before this amendment comes into force and which do not fall under paragraph 2 may continue to be placed on the market without notification until 30 April 2024. The Notification Authority may extend the period by a maximum of one year. 4 The following provisions apply to existing substances for which notification was given before this amendment comes into force:
156 Inserted by No I of the O of 11 March 2022, in force since 1 May 2022 (AS 2022 220). |